Learn innovative techniques for analyzing and testing for extractables and leachables in biopharmaceutical development. Recording of 2 days event sessions [20 video sessions].

Learn about best practices and innovative approaches to genotoxic and other mutagenic impurities control. Recording of 2 days event sessions [13 video sessions].

Explore the latest insights in HPAPIs handling together with occupational toxicologists and containment experts. Recording of 2 days event sessions [15 video sessions].

What actions medical device manufacturers could take to strengthen the implementation strategy for EU MDR and IVDR? Recording of 2 days event sessions [15 video sessions].

What is next in testing and analyzing for extractables and leachables in biopharmaceutical development and release? Recording of 2 days event sessions [12 video sessions].

Review drug impurity profiling strategies in line with regulatory guidelines, new nitrosamine regulations. Recording of 2 days event sessions [14 video sessions].

Explore how pioneering pharma companies are approaching HPAPI development and processing. Recording of 2 days event sessions [12 video sessions].

Analytical methods for E&L, regulatory updates & compliance, risk based E&L programs, toxicological risk assessment. Recording of 2 days event sessions [13 video sessions].

How to benchmark R&D activities and restructure R&D teams to protect against disruption and find new ways of innovation? Recording of 2 days event sessions [15 video sessions].